- Home
- DOMO vs PRQR Comparison
DOMO vs PRQR Comparison
Compare DOMO & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMO
- PRQR
- Stock Information
- Founded
- DOMO 2010
- PRQR 2012
- Country
- DOMO United States
- PRQR Netherlands
- Employees
- DOMO N/A
- PRQR N/A
- Industry
- DOMO Computer Software: Prepackaged Software
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- DOMO Technology
- PRQR Health Care
- Exchange
- DOMO Nasdaq
- PRQR Nasdaq
- Market Cap
- DOMO 324.2M
- PRQR 309.5M
- IPO Year
- DOMO 2018
- PRQR 2014
- Fundamental
- Price
- DOMO $8.09
- PRQR $1.37
- Analyst Decision
- DOMO Hold
- PRQR Strong Buy
- Analyst Count
- DOMO 6
- PRQR 6
- Target Price
- DOMO $10.42
- PRQR $8.50
- AVG Volume (30 Days)
- DOMO 409.3K
- PRQR 723.0K
- Earning Date
- DOMO 03-06-2025
- PRQR 03-13-2025
- Dividend Yield
- DOMO N/A
- PRQR N/A
- EPS Growth
- DOMO N/A
- PRQR N/A
- EPS
- DOMO N/A
- PRQR N/A
- Revenue
- DOMO $317,044,000.00
- PRQR $20,235,014.00
- Revenue This Year
- DOMO $0.86
- PRQR $39.44
- Revenue Next Year
- DOMO $1.94
- PRQR N/A
- P/E Ratio
- DOMO N/A
- PRQR N/A
- Revenue Growth
- DOMO N/A
- PRQR 196.41
- 52 Week Low
- DOMO $6.11
- PRQR $1.25
- 52 Week High
- DOMO $10.15
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- DOMO 48.18
- PRQR 25.70
- Support Level
- DOMO $7.58
- PRQR $1.25
- Resistance Level
- DOMO $9.02
- PRQR $1.87
- Average True Range (ATR)
- DOMO 0.37
- PRQR 0.09
- MACD
- DOMO -0.06
- PRQR -0.02
- Stochastic Oscillator
- DOMO 35.54
- PRQR 21.43
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.